Product NDC: | 0299-4500 |
Proprietary Name: | Clindagel |
Non Proprietary Name: | clindamycin phosphate |
Active Ingredient(s): | 10 mg/mL & nbsp; clindamycin phosphate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0299-4500 |
Labeler Name: | Galderma Laboratories, L.P. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050782 |
Marketing Category: | NDA |
Start Marketing Date: | 20001127 |
Package NDC: | 0299-4500-00 |
Package Description: | 7.3 mL in 1 BOTTLE (0299-4500-00) |
NDC Code | 0299-4500-00 |
Proprietary Name | Clindagel |
Package Description | 7.3 mL in 1 BOTTLE (0299-4500-00) |
Product NDC | 0299-4500 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clindamycin phosphate |
Dosage Form Name | GEL |
Route Name | TOPICAL |
Start Marketing Date | 20001127 |
Marketing Category Name | NDA |
Labeler Name | Galderma Laboratories, L.P. |
Substance Name | CLINDAMYCIN PHOSPHATE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |